PROCEEDINGS ABSTRACT |
open access
Endocrinopathies associated with immune checkpoint inhibitors: incidence, clinical presentation, and management
Angeliki M. Stamatouli*
Section of Endocrinology and Metabolism, Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA, USA (AMS)
*corresponding author (angeliki.stamatouli@vcuhealth.org)
Received: 01 April 2026; Accepted: 04 April 2026; Published: 05 April 2026
DOI: 10.5281/zenodo.19426873
Full-text proceedings abstract: PDF
Keywords: cancer; endocrinopathies; immune checkpoint inhibitors; immune-related adverse events; toxicities
Stamatouli A. M.: Endocrinopathies associated with immune checkpoint inhibitors: incidence, clinical presentation, and management. Colloq. Erud. 1: 1–2 (2026).
https://doi.org/10.5281/zenodo.19426873
VOLUME 1 (2026) ▪ NEXT PROCEEDINGS ABSTRACT